United Therapeutics CorporationUTHRNASDAQ
LOADING
|||
Cash Flow Performance
Modest growth trend.
Left:
||||
Free cash flow yield
Latest
6.78%
↑ 13% above average
Average (9y)
5.97%
Historical baseline
Range
High:12.54%
Low:-7.52%
CAGR
+4.3%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 6.78% | -6.7% |
| 2023 | 7.26% | +38.5% |
| 2022 | 5.25% | +6.6% |
| 2021 | 4.92% | -52.6% |
| 2020 | 10.38% | +237.9% |
| 2019 | -7.52% | -160.0% |
| 2018 | 12.54% | +110.4% |
| 2017 | 5.96% | -37.7% |
| 2016 | 9.56% | +106.8% |
| 2015 | 4.62% | - |